Is metabolic syndrome a risk factor in hepatectomy? A meta-analysis with subgroup analysis for histologically confirmed hepatic manifestations

BACKGROUND: Metabolic syndrome (MetS) is a risk factor in surgery. MetS can progress to metabolic (dysfunction)-associated fatty liver disease (MAFLD), a vast-growing etiology of primary liver tumors which are major indications for liver surgery. The aim of this meta-analysis was to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Murtha-Lemekhova, Anastasia, Fuchs, Juri, Feiler, Svenja, Schulz, Erik, Teroerde, Miriam, Kalkum, Eva, Klotz, Rosa, Billeter, Adrian, Probst, Pascal, Hoffmann, Katrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802506/
https://www.ncbi.nlm.nih.gov/pubmed/35101037
http://dx.doi.org/10.1186/s12916-022-02239-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802506/
https://www.ncbi.nlm.nih.gov/pubmed/35101037
http://dx.doi.org/10.1186/s12916-022-02239-x

Ejemplares similares